Bone health in children and adolescents with perinatal HIV infection

Thanyawee Puthanakit1, George K Siberry

  • 1Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Insights

Lifelong HIV infection and ART may impact bone health in children. More research is needed to understand bone mineral density (BMD) and fracture risks in youth with HIV.

Area of Science:

  • Pediatric Bone Health
  • HIV/AIDS Research
  • Pharmacology

Background:

  • Long-term effects of HIV and antiretroviral therapy (ART) on bone health in children are unknown.
  • Bone health in youth requires interpretation considering developmental changes.
  • Low bone mineral density (BMD) is common in perinatally HIV-infected youth, particularly in low-income settings.

Purpose of the Study:

  • To review the current understanding of bone health in children with lifelong HIV infection.
  • To highlight concerns regarding tenofovir's potential impact on BMD and bone mass accrual.
  • To identify strategies for maintaining bone health and areas for future research.

Main Methods:

  • Literature review and synthesis of existing data on HIV, ART, and pediatric bone health.
  • Analysis of factors influencing bone development in HIV-infected youth.
  • Discussion of nutritional, lifestyle, and pharmacological considerations.

Main Results:

  • Limited data suggest low BMD is prevalent in HIV-infected youth.
  • Tenofovir raises concerns for potential negative effects on bone accrual.
  • Current data on fracture risk in this population are very limited.

Conclusions:

  • HIV-infected youth may not achieve optimal peak bone mass, increasing future osteoporosis and fracture risk.
  • Good nutrition, vitamin D, calcium, exercise, and avoidance of alcohol/smoking are crucial.
  • Further research is essential to guide therapies and monitoring for bone fragility in HIV-infected youth.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...